Wong S G, Card J W, Racz W J
Department of Pharmacology and Toxicology, Faculty of Health Sciences, Queen's University, Ont., K7L 3N6, Kingston, Canada.
Toxicol Lett. 2000 Aug 16;116(3):171-81. doi: 10.1016/s0378-4274(00)00218-6.
Bromobenzene (BB) and furosemide (FS) are two hepatotoxicants whose bioactivation to reactive intermediates is crucial to the development of liver injury. However, the events which lead to hepatocellular toxicity following metabolite formation and covalent binding to cellular macromolecules remain unknown. The present study was undertaken to investigate the effect of administered BB and FS on mitochondrial total glutathione (GSH+GSSG, henceforth referred to as glutathione) content and respiratory function as potential initiating mechanisms of the hepatotoxicity of these compounds in the mouse. Bromobenzene (2 g/kg i.p.) significantly decreased mitochondrial glutathione to 48% of control at 3 h post administration, and to 41% at 4 h. This decrease in mitochondrial glutathione was subsequent to a significant decrease in cytosolic glutathione to 64 and 28% of control at 1 and 2 h, respectively. Oxygen consumption supported by complex I (glutamate-supported) of the respiratory chain was not inhibited by BB until 4 h, where state 3 (active) respiration was reduced to 16% of control. This resulted in a decreased respiratory control ratio (RCR) for complex I-supported respiration. Complex II (succinate)-supported state 3 and state 4 respiration were unaffected by BB until 4 h, at which time they were reduced to 57 and 48% of control, respectively. However, the similar reductions in state 3 and state 4 respiratory rates did not alter the corresponding RCR for complex II. Overt hepatic injury was detected at 4 h, with plasma alanine aminotransferase (ALT) activity increasing significantly at this time point. In contrast to the effects of BB, FS administration (400 mg/kg i.p.) did not alter mitochondrial or cytosolic glutathione, and had no effect on respiration supported by complex I or II for up to 5 h following dosing. However, ALT activity was significantly increased 5 h following FS administration. These results suggest that inhibition of mitochondrial respiratory function coinciding with a decrease in mitochondrial glutathione content may be crucial to the initiation of BB-induced hepatotoxicity, while such events are not required for the initiation of FS-induced hepatotoxicity.
溴苯(BB)和速尿(FS)是两种肝毒性物质,它们生物活化形成反应性中间体对于肝损伤的发生至关重要。然而,代谢产物形成并与细胞大分子共价结合后导致肝细胞毒性的具体过程仍不清楚。本研究旨在探讨给予BB和FS对小鼠线粒体总谷胱甘肽(GSH+GSSG,以下简称谷胱甘肽)含量及呼吸功能的影响,作为这些化合物肝毒性潜在起始机制的研究。溴苯(2 g/kg腹腔注射)给药后3小时,线粒体谷胱甘肽显著降至对照组的48%,4小时时降至41%。线粒体谷胱甘肽的这种降低是在胞质谷胱甘肽分别在1小时和2小时显著降至对照组的64%和28%之后出现的。呼吸链复合体I(谷氨酸支持)所支持的氧消耗在4小时前未被BB抑制,此时状态3(活性)呼吸降至对照组的16%。这导致复合体I支持的呼吸的呼吸控制率(RCR)降低。复合体II(琥珀酸)支持的状态3和状态4呼吸在4小时前未受BB影响,此时它们分别降至对照组的57%和48%。然而,状态3和状态4呼吸速率的类似降低并未改变复合体II相应的RCR。4小时时检测到明显的肝损伤,此时血浆丙氨酸转氨酶(ALT)活性显著增加。与BB的作用相反,给予FS(400 mg/kg腹腔注射)在给药后长达5小时内未改变线粒体或胞质谷胱甘肽,对复合体I或II支持的呼吸也无影响。然而,FS给药后5小时ALT活性显著增加。这些结果表明,线粒体呼吸功能受抑制并伴随线粒体谷胱甘肽含量降低可能对BB诱导的肝毒性起始至关重要,而这些事件并非FS诱导的肝毒性起始所必需。